Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - JUNIPER PHARMACEUTICALS INC | d214176d8k.htm |
Exhibit 16.1
June 13, 2016
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Juniper Pharmaceuticals, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of Juniper Pharmaceuticals, Inc. for the event that occurred on June 13, 2016. We agree with the statements concerning our Firm in such Form 8-K.
Very truly yours,
/s/ BDO USA, LLP
BDO USA, LLP